PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18463318-6	2008	Atorvastatin (30 mg.kg(-1).day(-1)) significantly attenuated proteinuria and glomerulosclerosis and normalized renal oxidative stress, TGF-beta1, fibronectin, MCP-1 and LOX-1 expression, and eNOS activity and expression.	Atorvastatin	0-12	oxidized low density lipoprotein receptor 1	Rattus norvegicus	169-174	
24756769-0	2014	Berberine combined with atorvastatin downregulates LOX-1 expression through the ET-1 receptor in monocyte/macrophages.	Atorvastatin	24-36	oxidized low density lipoprotein receptor 1	Rattus norvegicus	51-56	
24756769-4	2014	In the present study, we aimed to investigate the effect of berberine combined with atorvastatin on LOX-1 and explore the underlying molecular mechanism involved.	Atorvastatin	84-96	oxidized low density lipoprotein receptor 1	Rattus norvegicus	100-105	
24756769-10	2014	Furthermore, plasma ET-1 levels and LOX-1 expression were decreased by berberine combined with atorvastatin treatment, and the inhibitory effect on LOX-1 was impeded by an ET-1 receptor antagonist.	Atorvastatin	95-107	oxidized low density lipoprotein receptor 1	Rattus norvegicus	36-41	
24756769-11	2014	The results demonstrated that berberine combined with atorvastatin downregulates LOX-1 expression through ET-1 receptors in monocyte/macrophages in vitro and in vivo.	Atorvastatin	54-66	oxidized low density lipoprotein receptor 1	Rattus norvegicus	81-86